You are here

  • Home
  • Archive
  • Volume 26, Issue 5
  • High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient’s satisfaction

Article metrics

Article menu
Download PDFPDF
Original article
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient’s satisfaction

 

Online download statistics by month:

Online download statistics by month: April 2018 to March 2024

AbstractFullPdf
Apr 201824814
May 201814522
Jun 20185900
Jul 20184202
Aug 20186805
Sep 20186217
Oct 20184307
Nov 20184400
Dec 20185700
Jan 20199112
Feb 20196301
Mar 20197710
Apr 201910400
May 20197801
Jun 201910200
Jul 20195620
Aug 201920222
Sep 2019359612
Oct 2019738107
Nov 201931233
Dec 201919712
Jan 202020312
Feb 202034142
Mar 202020620
Apr 202018303
May 202016600
Jun 202010300
Jul 202012311
Aug 20207310
Sep 202014100
Oct 202016900
Nov 202016700
Dec 202010300
Jan 202113510
Feb 202118932
Mar 202116623
Apr 202117010
May 20218401
Jun 2021611
Jul 2021210
Aug 2021100
Sep 2021200
Oct 202114610
Nov 202121250
Dec 202116110
Jan 202214061
Feb 202219600
Mar 202219712
Apr 202212112
May 202213200
Jun 202219020
Jul 202219042
Aug 202219150
Sep 202221824
Oct 202234263
Nov 202216914
Dec 20227700
Jan 202310423
Feb 202317022
Mar 20238240
Apr 202310000
May 20239400
Jun 20238503
Jul 20237200
Aug 202311310
Sep 20236410
Oct 202312203
Nov 20237130
Dec 20238630
Jan 20244911
Feb 20245601
Mar 202411021
Total9940102104